# Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas

> **NCT06798935** · PHASE2 · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Rectovaginal Fistula
- Anovaginal Fistula

## Interventions

- **PROCEDURE:** autologous platelet-rich stroma

## Key facts

- **NCT ID:** NCT06798935
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-11
- **Primary completion:** 2024-09-04
- **Final completion:** 2024-09-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798935, "Feasibility and Safety of Additional Injection of Autologous Platelet-rich Stroma to Surgical Treatment of Rectovaginal Fistulas". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06798935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*